81 related articles for article (PubMed ID: 498157)
1. Phase II trial of cis-dichlorodiammineplatinum(II) in cancer of the bilharzial bladder.
Gad-el-Mawla N; Chevlen E; Hamza R; Ziegler JL
Cancer Treat Rep; 1979; 63(9-10):1577-8. PubMed ID: 498157
[No Abstract] [Full Text] [Related]
2. Phase II trial of adriamycin in carcinoma of the bilharzial bladder.
Gad-el-Mawla N; Hamza R; Chevlen E; Ziegler JL
Cancer Treat Rep; 1979 Feb; 63(2):227-8. PubMed ID: 445499
[No Abstract] [Full Text] [Related]
3. Cis-dichlorodiammineplatinum(II) in advanced bladder cancer.
Yagoda A; Watson RC; Gonzalez-Vitale JC; Grabstald H; Whitmore WF
Cancer Treat Rep; 1976 Jul; 60(7):917-23. PubMed ID: 1009522
[TBL] [Abstract][Full Text] [Related]
4. Randomized phase II trial of hexamethylmelamine versus pentamethylmelamine in carcinoma of the bilharzial bladder.
Gad-el-Mawla N; Ziegler JL; Hamza R; Elserafi M; Khaled H
Cancer Treat Rep; 1984 May; 68(5):793-4. PubMed ID: 6426792
[No Abstract] [Full Text] [Related]
5. Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26.
Gad-el-Mawla NM; Muggia FM; Hamza MR; El-Morsi B; Sherif M; Mansour MA; Khafagy M; El-Sebai IT
Cancer Treat Rep; 1978 Jul; 62(7):993-6. PubMed ID: 99234
[No Abstract] [Full Text] [Related]
6. Phase II trial of methotrexate in carcinoma of the bilharzial bladder.
Gad-el-Mawla N; Hamsa R; Cairns J; Anderson T; Ziegler JL
Cancer Treat Rep; 1978 Jul; 62(7):1075-6. PubMed ID: 356969
[No Abstract] [Full Text] [Related]
7. Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report.
Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D
Cancer Treat Rep; 1979; 63(9-10):1621-7. PubMed ID: 291484
[No Abstract] [Full Text] [Related]
8. Clinical trial of combined therapy with adriamycin and cis-dichlorodiammineplatinum(II).
Mills RC; Maurer LH; Forcier RJ; Grace WR; Burke GP; Karp DD; Smith RC; Mcintyre OR; Bean C
Cancer Treat Rep; 1977; 61(3):477-9. PubMed ID: 872146
[No Abstract] [Full Text] [Related]
9. [Phase II study on cis-diamminedichloroplatinum (II) by a collaborative study].
Gan To Kagaku Ryoho; 1982 Jan; 9(1):46-54. PubMed ID: 6892191
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of bleomycin in bilharzial bladder cancer.
Gad-el-Mawla N; Hamsa R; Chevlen E; Ziegler JL
Cancer Treat Rep; 1978 Jul; 62(7):1109-10. PubMed ID: 80271
[TBL] [Abstract][Full Text] [Related]
11. Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.
Merrin CE
Cancer Treat Rep; 1979; 63(9-10):1579-84. PubMed ID: 574057
[No Abstract] [Full Text] [Related]
12. Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma.
Ahmann DL; Edmonson JH; Frytak S; Kvols LK; Bisel HF; Rubin J
Cancer Treat Rep; 1978 Jan; 62(1):151-3. PubMed ID: 626995
[No Abstract] [Full Text] [Related]
13. Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study.
Rossof AH; Coltman CA; Jones SE; Talley RW
Cancer Treat Rep; 1979; 63(9-10):1605-8. PubMed ID: 498159
[TBL] [Abstract][Full Text] [Related]
14. Phase II chemotherapy trials of 5-FU, cyclophosphamide, ifosfamide, and vincristine in carcinoma of the bilharzial bladder.
Gad-el-Mawla N; Ziegler JL; Hamza R; Elserafi M; Khaled H
Cancer Treat Rep; 1984 Feb; 68(2):419-21. PubMed ID: 6697330
[No Abstract] [Full Text] [Related]
15. Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer.
Lacave AJ; Izarzugaza I; Antón Aparicio LM; Valle Pereda M; Gracia Marco JM; Buesa JM
Am J Clin Oncol; 1983 Feb; 6(1):35-8. PubMed ID: 6682284
[TBL] [Abstract][Full Text] [Related]
16. Helminths in the induction of cancer II. Schistosoma haematobium and bladder cancer.
Schwartz DA
Trop Geogr Med; 1981 Mar; 33(1):1-7. PubMed ID: 7018036
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.
Gogna NK; Matthews JH; Turner SL; Mameghan H; Duchesne GM; Spry N; Berry MP; Keller J; Tripcony L;
Radiother Oncol; 2006 Oct; 81(1):9-17. PubMed ID: 17011058
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer.
Casper ES; Gralla RJ; Kelsen DP; Cvitkovic E; Golbey RB
Cancer Treat Rep; 1979; 63(11-12):2107-9. PubMed ID: 575068
[No Abstract] [Full Text] [Related]
19. Intraarterial chemotherapy for bladder cancer.
Jacobs SC; Menashe DS
Prog Clin Biol Res; 1990; 350():101-6. PubMed ID: 1696738
[No Abstract] [Full Text] [Related]
20. The bilharzial bladder cancer and its relation to schistosomiasis. A statistical stud.
HASHEM M; ZAKI SA; HUSSEIN M
J Egypt Med Assoc; 1961; 44():579-97. PubMed ID: 14036077
[No Abstract] [Full Text] [Related]
[Next] [New Search]
